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Dry solvents were freshly distilled under argon from an appropriate drying agent before use. 
Dried N,N-dimethylformamide were purchased from Aldrich and used without further 
purification. [RhCp*Cl2]2 (99%) [12354-85-7] and Ag2CO3 (99%) [534-16-7] were purchased 
from Sigma-Aldrich. All other chemicals were purchased from Sigma-Aldrich, TCI, Alfa Aesar 
and Strem-Chemicals and used without further purification. All reactions dealing with air and 
moisture-sensitive compounds were carried out in oven-dried reaction flask under argon 
atmosphere with dry solvents. The abbreviation “rt” refers to reactions carried out 
approximately at 23 °C. Reaction mixtures were stirred using Teflon-coated magnetic stirring 
bars. Reaction temperatures were maintained using Thermowatch-controlled silicone oil baths. 
Thin-layer chromatography (TLC) was performed on silica gel plates and components were 
visualized by observation under UV light, and / or by treating the plates with p-anisaldehyde or 
phosphomolybdic acid solutions, followed by heating. Flash chromatography was carried out 
on silica gel unless otherwise stated. Dryings were performed with anhydrous Na2SO4 or 
MgSO4. Concentration refers to the removal of volatile solvents via distillation using a Büchi 
rotary evaporator followed by residual solvent removal under high vacuum. Melting points 
(m.p.) were determined with an M-560 BÜCHI apparatus. NMR spectra were recorded in 
CDCl3, at 300 MHz (Varian), 400 MHz (Varian) or 500 MHz (Varian), unless other solvent is 
specified. Carbon types and structure assignments were determined from DEPT-NMR. NMR 
spectra were analyzed using MestreNova© NMR data processing software 
(www.mestrelab.com). 1,3,5-Trimethoxybenzene was used as internal standard. The following 
abbreviations are used to indicate signal multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; 
dd, double doublet; ddd, doublet of doublet of doublets; td, triple doublet; dt, doublet of triplets; 
dq, doublet of quartet; m, multiplet; brs, broad singlet. Mass spectra (ESI-MS) were acquired 
using IT-MS Bruker AmaZon SL at CIQUS and also using chemical ionization (CI) electron 
impact (EI), electrospray ionization (ESI) or (APCI) atmospheric-pressure chemical ionization 
at the CACTUS facility of the University of Santiago de Compostela. The reactions were 
monitored by TLC. 
S4
Table S1. Optimization of the reaction conditions.a
a Reaction conditions: 0.20 mmol of 1a, catalyst (2.5 mol%), 2 equiv. of oxidant, solvent (0.8 mL), 12 h. Yields 
determined by internal standard. b Isolated yield. c 5 mol% of catalyst. d AgSbF6 (1 equiv.) was used as additive. e 
1 mol% of catalyst, 0.5 equiv. oxidant. f 2 equiv. AgOAc, 1 equiv. 1,4-benzoquinone. g 1 equiv. NaOAc. h 1 equiv. 
Ag2CO3 
Entry Catalyst Oxidant Solvent T (ºC) Yield (%)
1 [Cp*RhCl2]2 Cu(OAc)2.H2O tAmOH 100 50
2 [Cp*RhCl2]2 Cu(OAc)2.H2O DMF 120 25
3 [Cp*RhCl2]2 Ag2CO3 DMF 120 82b
4 [Cp*RhCl2]2 Ag2CO3 DCE 80 20
5 [Cp*RhCl2]2 Ag2CO3 toluene 110 36
6 [(p-cymene) RuCl2]2 Ag2CO3 DMF 120 28
7 [Cp*IrCl2]2 Ag2CO3 DMF 120 -
8 [Cp*Rh(CH3CN)3](SbF6)2 Ag2CO3 DMF 120 21b,c
9 [Cp*RhCl2]2 Ag2CO3 DMF 120 21d
10 [Cp*RhCl2]2 Ag2CO3 MeOH 80 71
11 [Cp*RhCl2]2 Ag2CO3 HFIP 80 26e
12 [Cp*RhCl2]2 Ag2CO3 HFIP 80 48b
13 [Cp*RhCl2]2 1,3-DNB DMF 120 28
14 [Cp*RhCl2]2 BQ/AgOAc DMF 120 <5f
15 [Cp*RhCl2]2 Air DMF 120 <5g













General procedure (A) for preparation of acid precursors 1c, 1e, 1h, 1i, 1j, 1k and 1l 
(exemplified for the synthesis of (E)-10-phenyldec-2-en-9-ynoic acid, 1e).
A flame-dried Schlenk flask under argon equipped with a Teflon septum and magnetic stir bar 
was charged with CuI (135.8 mg, 0.71 mmol) and Pd(PPh3)4 (412.5 mg, 0.36 mmol). Et3N (47.5 
mL), iodobenzene (4.0 mL, 35.66 mmol) and oct-7-yn-1-ol (3.0 g, 23.77 mmol) were 
sequentially added. The reaction mixture was stirred at rt. After 20 h, the reaction mixture was 
concentrated in vacuo. Purification of the crude product by flash chromatography on silica gel 
(1:10 to 1:4 EtOAc: Hexane) afforded 8-phenyloct-7-yn-1-ol (S1) as a yellow oil (4.6 g, 96 % 
yield). 1H NMR (300 MHz, CDCl3): δ 7.44 – 7.39 (m, 2H), 7.32 – 7.26 (m, 3H), 3.66 (td, J = 6.6, 
2.4 Hz, 2H), 2.43 (t, J = 6.9 Hz, 2H), 2.08 – 1.93 (m, 1H), 1.69 – 1.55 (m, 4H), 1.54 – 1.37 (m, 
4H). 13C NMR (75 MHz, CDCl3): δ 131.60 (CH), 128.27 (CH), 127.58 (CH), 124.07 (C), 90.34 
(C), 80.75 (C), 62.90 (CH2), 32.68 (CH2), 28.75 (CH2), 25.38 (CH2), 19.41 (CH2). HRMS (APCI-
FIA-TOF): m/z calculated for C14H19O ([M+H]+) 203.1429, found 203.1430.
DMSO (1.3 mL, 17.79 mmol) in CH2Cl2 (1.9 mL) was added dropwise to a solution of oxalyl 
chloride (0.76 mL, 8.90 mmol) in CH2Cl2 (16.5 mL) at –78 °C. The reaction was stirred for 10 
min and then a solution of 8-phenyloct-7-yn-1-ol (1.0 g, 4.94 mmol) in CH2Cl2 (3.5 mL,) was 
added slowly. After 45 min Et3N (3.4 mL, 24.71 mmol) was added at –78 °C. After stirring at 
that temperature for 30 min, the mixture was warmed to rt and stirred for 45 min. H2O (30 mL) 
was then added, the organic phase was separated and washed with HCl (1.0 M solution), 
NaHCO3 (sat) and brine. The organic phases were dried and carefully concentrated under 
vacuum at 0 °C. The crude 8-phenyloct-7-ynal was obtained in quantitative yield as yellow oil 
and submitted to the next step without purification. To a solution of ethyl 2-(triphenyl-l5-
phosphaneylidene)acetate (4.30 g, 12.35 mmol) in CH2Cl2 (10 mL) at 0 ºC was added dropwise 
the crude 8-phenyloct-7-ynal (990 mg, 4.94 mmol). The reaction mixture was stirring at. After 
Scheme S1. General procedure A for preparation of acid precursors
S6
18h, the solvent was evaporated in vacuo and the crude was purified by flash chromatography 
(pentane:diethylether 8:1) to obtain ethyl (E)-10-phenyldec-2-en-9-ynoate (S2) (940 mg, 
70.5%). Colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.56 – 7.49 (m, 2H), 7.43 – 7.36 (m, 3H), 
7.10 (dt, J = 15.6, 6.9 Hz, 1H), 5.96 (dt, J = 15.6, 1.6 Hz, 1H), 4.31 (q, J = 7.1 Hz, 2H), 2.53 (t, 
J = 6.9 Hz, 2H), 2.42 – 2.29 (m, 2H), 1.79 – 1.69 (m, 2H), 1.69 – 1.56 (m, 4H), 1.40 (t, J = 7.1 
Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 166.7 (C), 149.1 (CH), 131.6 (CH), 128.2 (CH), 127.5 
(CH), 124.0 (C), 121.5 (CH), 90.0 (C), 80.8 (C), 60.1 (CH2), 32.1 (CH2), 28.5 (CH2), 28.4 (CH2), 
27.6 (CH2), 19.3 (CH2), 14.3 (CH3). HRMS (APCI-FIA-TOF): m/z calculated for C18H23O2 
([M+H]+) 271.1693, found 271.1693. 
A NaOH aqueous solution (8.8 mL, 1M mmol) was added to solution that contains ethyl (E)-
10-phenyldec-2-en-9-ynoate (S2, 600 mg, 2.21 mmol) in MeOH (4.1 mL). The reaction mixture 
was stirring at 45 ºC. After 20 h, a solution of HCl (10 %) was added to adjust the pH to 1. The 
mixture was extracted with EtOAc (3 x 10 mL). The combined organic layers were dried, and 
the solvent removed in vacuo. Purification of the crude product by flash chromatography on 
silica gel (1:5 to 2:1 EtOAc: Hexane) afforded (E)-10-phenyldec-2-en-9-ynoic acid (1e) as a 
colorless oil. 1H NMR (300 MHz, CDCl3): δ 11.03 (s, 1H), 7.47 – 7.37 (m, 2H), 7.34 – 7.26 (m, 
3H), 7.13 (dt, J = 15.6, 6.9 Hz, 1H), 5.87 (d, J = 15.6 Hz, 1H), 2.44 (t, J = 6.8 Hz, 2H), 2.35 – 
2.25 (m, 2H), 1.71 – 1.47 (m, 6H). 13C NMR (75 MHz, CDCl3): δ 172.3, 152.3, 131.7, 128.3, 
127.7, 124.1, 120.9, 90.1, 80.9, 32.3, 28.6, 28.5, 27.5, 19.4. HRMS (APCI-FIA-TOF): m/z 
calculated for C16H19O2 ([M+H]+) 243.1373, found 243.1380. 
(E)-9-Phenylnon-2-en-8-ynoic acid (1c)
This compound was prepared according to the previously described general 
procedure A, using 7-phenylhept-6-yn-1-ol instead of 8-phenyloct-7-yn-1-ol. 
White solid, m.p. 71 -72 ºC.   1H NMR (300 MHz, CDCl3): δ 7.45 – 7.35 (m, 
2H), 7.33 – 7.23 (m, 3H), 7.10 (dt, J = 15.6, 6.9 Hz, 1H), 5.87 (dt, J = 15.6, 
1.6 Hz, 1H), 2.47 – 2.39 (m, 2H), 2.36 – 2.25 (m, 2H), 1.74 – 1.59 (m, 4H). 
13C NMR (75 MHz, CDCl3): δ 171.9 (C), 151.9 (CH), 131.7 (CH), 128.3 (CH), 127.7 (CH), 124.0 
(C), 121.04 (CH), 89.7 (C), 81.2 (C), 32.0 (CH2), 28.3 (CH2), 27.2 (CH2), 19.3 (CH2). HRMS 
(APCI-FIA-TOF): m/z calculated for C15H17O2 ([M+H]+) 229.1221, found 229.1223. 
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(E)-2-Methyl-8-phenyloct-2-en-7-ynoic acid (1h)
This compound was prepared according to the previously described general 
procedure A, using 6-phenylhex-5-yn-1-ol and ethyl ethyl 2-(triphenyl-λ5-
phosphaneylidene)propanoate instead of 8-phenyloct-7-yn-1-ol and ethyl 2-
(triphenyl-l5-phosphaneylidene)acetate. Light yellow solid, m.p. 77 -79 ºC.  1H 
NMR (300 MHz, CDCl3): δ 11.94 (brs, 1H), 7.34 – 7.26 (m, 2H), 7.22 – 7.12 (m, 3H), 6.85 (t, J 
= 7.1 Hz, 1H), 2.38 – 2.24 (m, 4H), 1.79 (s, 3H), 1.66 (p, J = 7.1 Hz, 2H). 13C NMR (75 MHz, 
CDCl3): δ 173.9 (C), 144.1 (CH), 131.6 (CH), 128.3 (CH), 128.1 (C), 127.7 (CH), 123.9 (C), 
89.3 (C), 81.4 (C), 28.0 (CH2), 27.5 (CH2), 19.1 (CH2), 12.1 (CH3). HRMS (APCI-FIA-TOF): 
m/z calculated for C15H16O2 ([M+H]+) 229.1225, found 229.1223.
(E)-2-Methyl-9-phenylnon-2-en-8-ynoic acid (1i)
This compound was prepared according to the previously described general 
procedure A, using 7-phenylhept-6-yn-1-ol and ethyl 2-(triphenyl-λ5-
phosphaneylidene)propanoate instead of 8-phenyloct-7-yn-1-ol and ethyl 2-
(triphenyl-l5-phosphaneylidene)acetate. Viscous oil.  1H NMR (300 MHz, 
CDCl3): δ 11.55 (brs, 1H), 7.45 – 7.40 (m, 2H), 7.33 – 7.27 (m, 3H), 7.01 – 
6.94 (m, 1H), 2.49 – 2.42 (m, 2H), 2.31 – 2.23 (m, 2H), 1.88 (s, 3H), 1.70 – 
1.61 (m, 4H). 13C NMR (75 MHz, CDCl3): δ 174.0 (C), 144.9 (CH), 131.6 (CH), 128.2 (CH), 
127.6 (CH), 127.4 (CH), 124.0 (C), 89.8 (C), 81.1 (C), 28.5 (CH2), 28.4 (CH2), 27.7 (CH2), 19.3 
(CH2), 12.0 (CH3). HRMS (APCI-FIA-TOF): m/z calculated for C16H19O2 ([M+H]+) 243.1378, 
found 243.1380.
(E)-9-(3,5-Dimethylphenyl)-2-methylnon-2-en-8-ynoic acid (1j)
This compound was prepared according to the previously described 
general procedure A, using 7-phenylhept-6-yn-1-ol and ethyl ethyl 2-
(triphenyl-λ5-phosphaneylidene) propanoate instead of 8-phenyloct-7-yn-1-
ol and ethyl 2-(triphenyl-l5-phosphaneylidene)acetate. 1-bromo-3,5-
dimethylbenzene was used for the Sonogashira coupling. Amorphous 
yellow solid. 1H NMR (300 MHz, CDCl3): δ 11.54 (brs, 1H), 6.93 (s, 2H), 
6.85 (t, J = 7.5 Hz, 1H), 6.79 (s, 1H), 2.37 – 2.26 (m, 2H), 2.17 (s, 6H), 1.79 
– 1.72 (m, 3H), 1.59 – 1.49 (m, 4H). 13C NMR (75 MHz, CDCl3): δ 174.0 (C), 145.0 (CH), 137.8 
(C), 129.6 (CH), 129.3 (CH), 127.4 (C), 123.6 (C), 89.0 (C), 81.3 (C), 28.5 (CH2), 28.5 (CH2), 
27.7 (CH2), 21.2 (CH3), 19.3 (CH2), 12.1 (CH3). HRMS (APCI-FIA-TOF): m/z calculated for 
C15H16O2 ([M+H]+) 271.1695, found 271.1698.
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(E)-2-Methyl-9-(naphthalen-1-yl)non-2-en-8-ynoic acid (1k)
This compound was prepared according to the previously described 
general procedure A, using 7-phenylhept-6-yn-1-ol and ethyl 2-(triphenyl-
λ5-phosphaneylidene) propanoate instead of 8-phenyloct-7-yn-1-ol and 
ethyl 2-(triphenyl-l5-phosphaneylidene)acetate. 1-bromonaphthalene was 
used for the Sonogashira coupling. Light yellow solid, m.p. 72-74 ºC. 1H 
NMR (300 MHz, CDCl3): δ 12.10 (brs, 1H), 8.43 (d, J = 8.3 Hz, 1H), 7.92 
– 7.79 (m, 2H), 7.71 (d, J = 7.1 Hz, 1H), 7.67 – 7.52 (m, 2H), 7.50 – 7.41 
(m, 1H), 7.04 (t, J = 7.3 Hz, 1H), 2.63 (t, J = 6.4 Hz, 2H), 2.38 – 2.27 (m, 2H), 1.93 (s, 3H), 
1.84 – 1.70 (m, 4H). 13C NMR (75 MHz, CDCl3): δ 174.0 (C), 144.9 (CH), 133.5 (C), 133.3 (C), 
130.1 (CH), 128.3 (CH), 128.1 (CH), 127.5 (C), 126.6 (CH), 126.3 (CH), 126.3 (CH), 125.3 
(CH), 121.7 (C), 94.9 (C), 79.1 (C), 28.6 (CH2), 28.5 (CH2), 27.8 (CH2), 19.6 (CH2), 12.1 (CH3). 
HRMS (APCI-FIA-TOF): m/z calculated for C20H21O2 ([M+H]+) 293.1537, found 293.1536.
(E)-2-Methyl-9-(4-(trifluoromethyl)phenyl)non-2-en-8-ynoic acid (1l)
This compound was prepared according to the previously described 
general procedure A, using 7-phenylhept-6-yn-1-ol and ethyl 2-(triphenyl-
λ5-phosphaneylidene) propanoate instead of 8-phenyloct-7-yn-1-ol and 
ethyl 2-(triphenyl-l5-phosphaneylidene)acetate. 1-bromo-4-(trifluoromethyl) 
Benzene was used for the Sonogashira coupling. Amorphous yellowish 
solid. 1H NMR (300 MHz, CDCl3): δ 11.51 (brs, 1H), 7.46 – 7.35 (m, 4H), 
6.88 – 6.81 (m, 1H), 2.39 – 2.29 (m, 2H), 2.21 – 2.10 (m, 2H), 1.75 (s, 3H), 
1.58 – 1.50 (m, 4H). 13C NMR (75 MHz, CDCl3): δ 174.0 (C), 144.8 (CH), 
131.9 (CH), 129.4 (C, q, J = 32.8 Hz), 127.6 (C), 126.8 (C), 125.2 (CH, q, J = 4.0 Hz), 120.5 
(CF3, q, J = 272.6 Hz), 92.7 (C), 80.0 (C), 28.5 (CH2), 28.2 (CH2), 27.7 (CH2), 19.3 (CH2), 12.0 
(CH3). HRMS (APCI-FIA-TOF): m/z calculated for C17H18F3O2 ([M+H]+) 311.1257, found 
311.1259.
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General procedure (B) for preparation of acid precursors 1a, 1b, 1d, 1f, 1g, 1m and 1n 
(exemplified for the synthesis of (E)-4-((5-Phenylpent-4-yn-1-yl)oxy)but-2-enoic acid, 1d).
A flame-dried Schlenk flask under argon equipped with a Teflon septum and magnetic stir bar 
was charged with CuI (271.7 mg, 1.43 mmol) and Pd(PPh3)4 (824.3 mg, 0.71 mmol). Et3N (95.0 
mL), iodobenzene (8.0 mL, 71.33 mmol) and 4-pentyn-1-ol (4.0 g, 47.55 mmol) were 
sequentially added. The reaction mixture was stirred at rt, and after 20 h concentrated in vacuo. 
Purification of the crude product by flash chromatography on silica gel (1:10 to 1:2 EtOAc: 
Hexane) afforded 5-phenylpent-4-yn-1-ol as an orange oil (7.4 g, 97% yield). The NMR and 
MS data were consistent with those previously published. 1 
PPh3 (163.7 mg, 0.62 mmol) was added to a solution of 5-phenylpent-4-yn-1-ol (2.0 g, 12.48 
mmol) and ethyl buta-2,3-dienoate (2.9 mL, 24.97 mmol) in benzene (27.7 mL). To this orange 
solution, acetic acid (0.14 mL, 2.49 mmol) was added and the reaction was heated up to 60 
ºC. After 16 h, the solvent was removed in vacuo. Purification of the crude product by flash 
chromatography on silica gel (1:20 to 1:4 EtOAc: Hexane) afforded ethyl (E)-4-((5-Phenylpent-
4-yn-1-yl)oxy)but-2-enoate as a pale yellow oil (1.9 g, 58 % yield). 1H NMR (300 MHz, CDCl3): 
δ 7.45 – 7.37 (m, 2H), 7.33 – 7.26 (m, 3H), 6.99 (dt, J = 15.7, 4.2 Hz, 1H), 6.11 (dt, J = 15.7, 
2.1 Hz, 1H), 4.26 – 4.16 (m, 4H), 3.65 (t, J = 6.0 Hz, 2H), 2.56 (t, J = 7.0 Hz, 2H), 1.91 (p, J = 
6.9, 6.5 Hz, 2H), 1.30 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 166.5 (C), 144.6 (CH), 
131.7 (CH), 128.3 (CH), 127.7 (CH), 123.9 (C), 121.3 (CH), 89.4 (C), 81.1 (C), 69.6 (CH2), 
60.5 (CH2), 29.0 (CH2), 16.3 (CH2), 14.4 (CH3). HRMS (APCI-FIA-TOF): m/z calculated for 
C17H21O3 ([M+H]+) 273.1483, found 273.1485.
A NaOH aqueous solution (22.4 mL, 1M) was added to a solution that contains ethyl (E)-4-((5-
Phenylpent-4-yn-1-yl)oxy)but-2-enoate (1500 mg, 5.51  mmol) in MeOH (10.2 mL). The 
reaction mixture was stirred at 45 ºC. After 20 h, a solution of HCl (10 %) was added to adjust 
the pH to 1. The mixture was extracted with EtOAc (3 x 20 mL). The combined organic layers 
were dried and the solvent removed in vacuo. Purification of the crude product by flash 
chromatography on silica gel (1:5 to 2:1 EtOAc: Hexane) afforded (E)-4-((5-Phenylpent-4-yn-
Scheme S2. General procedure B for preparation of acid precursors
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1-yl)oxy)but-2-enoic acid (1d) as a white solid, m.p. 62-64 ºC, (1.23 g, 92 % yield). 1H NMR 
(300 MHz, CDCl3): δ 11.64 (brs, 1H), 7.47 – 7.39 (m, 2H), 7.35 – 7.27 (m, 3H), 7.11 (dt, J = 
15.7, 4.0 Hz, 1H), 6.15 (dt, J = 15.7, 2.1 Hz, 1H), 4.24 – 4.18 (m, 2H), 3.66 (t, J = 6.1 Hz, 2H), 
2.57 (t, J = 7.0 Hz, 2H), 1.93 (p, J = 6.5 Hz, 2H). 13C NMR (75 MHz, CDCl3): δ 171.9 (C), 147.5 
(CH), 131.6 (CH), 128.3 (CH), 127.7 (CH), 123.9 (C), 120.4 (CH), 89.3 (C), 81.1 (C), 69.6 
(CH2), 69.4 (CH2), 28.8 (CH2), 16.2 (CH2). HRMS (APCI-FIA-TOF): m/z calculated for 
C15H17O3 ([M+H]+) 245.1172, found 245.1172. 
(E)-4-((3-Phenylprop-2-yn-1-yl)oxy)but-2-enoic acid (1a)
This compound was prepared according to the previously described general 
procedure B, using prop-2-yn-1-ol instead of 4-pentyn-1-ol. White solid, m.p. 
66 -67 ºC. 1H NMR (300 MHz, CDCl3): δ 7.51 – 7.39 (m, 2H), 7.36 – 
7.28 (m, 3H), 7.19 – 7.04 (m, 1H), 6.22 – 6.08 (m, 1H), 4.45 (s, 2H), 4.34 (s, 2H). 13C 
NMR (75 MHz, CDCl3): δ 171.3 (C), 146.6 (CH), 131.9 (CH), 128.8 (CH), 128.5 (CH), 
122.5 (C), 120.9 (CH), 87.1 (C), 84.4 (C), 68.2 (CH2), 59.0 (CH2). HRMS (APCI-FIA-
TOF): m/z calculated for C13H13O3 ([M+H]+) 217.0855, found 217.0859. 
(E)-4-((4-Phenylbut-3-yn-1-yl)oxy)but-2-enoic acid (1b)
This compound was prepared according to the previously described general 
procedure B, using but-3-yn-1-ol instead of 4-pentyn-1-ol. White solid, m.p. 
80 -81 ºC.1H NMR (300 MHz, CDCl3): δ 11.51 (brs, 1H), 7.48 – 7.40 (m, 2H), 
7.35 – 7.27 (m, 3H), 7.11 (dt, J = 15.7, 4.0 Hz, 1H), 6.19 (dt, J = 15.7, 2.1 Hz, 
1H), 4.27 (dd, J = 4.1, 2.1 Hz, 2H), 3.72 (t, J = 6.9 Hz, 2H), 2.75 (t, J = 6.9 
Hz, 2H). 13C NMR (75 MHz, CDCl3): δ 171.9 (C), 147.1 (CH), 131.7 (CH), 128.3 (CH), 127.9 
(CH), 123.6 (C), 120.6 (CH), 86.5 (C), 81.8 (C), 69.5 (CH2), 69.4 (CH2), 20.9 (CH2). HRMS 
(APCI-FIA-TOF): m/z calculated for C14H15O3 ([M+H]+) 231.1016, found 231.1016. 
(E)-4-((6-Phenylhex-5-yn-1-yl)oxy)but-2-enoic acid (1f)
This compound was prepared according to the previously described general 
procedure B, using hex-5-yn-1-ol instead of 4-pentyn-1-ol. White solid, m.p. 
78 -79 ºC.1H NMR (300 MHz, CDCl3): δ 11.31 (brs, 1H), 7.33 – 7.26 (m, 
2H), 7.22 – 7.12 (m, 3H), 6.97 (dt, J = 15.7, 4.1 Hz, 1H), 6.00 (dt, J = 15.7, 
2.0 Hz, 1H), 4.06 – 4.00 (m, 2H), 3.42 (t, J = 6.2 Hz, 2H), 2.35 (t, J = 6.7 Hz, 
2H), 1.75 – 1.52 (m, 4H). 13C NMR (75 MHz, CDCl3): δ 171.8 (C), 147.5 
(CH), 131.6 (CH), 128.2 (CH), 127.6 (CH), 124.0 (C), 120.3 (CH), 89.9 (C), 81.0 (C), 70.7 
S11
(CH2), 69.2 (CH2), 28.8 (CH2), 25.4 (CH2), 19.2 (CH2). HRMS (IE-FIA-TOF): m/z calculated for 
C16H18O3 ([M]+) 258.1256, found 258.1258. 
(E)-4-(Hept-2-yn-1-yloxy)but-2-enoic acid (1g)
This compound was prepared according to the previously described general 
procedure B, using hept-2-yn-1-ol instead of 4-pentyn-1-ol. Viscous yellow 
oil. 1H NMR (300 MHz, CDCl3): δ 11.49 (brs, 1H), 7.11 – 6.99 (m, 1H), 6.12 
– 6.02 (m, 1H), 4.24 – 4.19 (m, 2H), 4.16 (s, 2H), 2.25 – 2.14 (m, 2H), 1.56 – 1.28 (m, 4H), 
0.88 (t, 3H). 13C NMR (75 MHz, CDCl3): δ 173.8 (C), 148.7 (CH), 122.7 (CH), 89.9 (C), 77.2 
(C), 69.8 (CH2), 60.7 (CH2), 32.6 (CH2), 24.0 (CH2), 20.4 (CH2), 15.6 (CH3). HRMS (APCI-FIA-
TOF): m/z calculated for C11H17O3 ([M+H]+) 197.1172, found 197.1172.
(E)-4-((4-(Thiophen-3-yl)but-3-yn-1-yl)oxy)but-2-enoic acid (1m)
This compound was prepared according to the previously described general 
procedure B, using 3-bromothiophene (90%) instead of iodobenzene. 
Amorphous white solid. 1H NMR (300 MHz, CDCl3): δ 10.99 (brs, 1H), 7.41 
(dd, J = 3.0, 1.2 Hz, 1H), 7.25 (dd, J = 5.0, 3.0 Hz, 1H), 7.17 – 7.03 (m, 2H), 
6.18 (dt, J = 15.7, 2.1 Hz, 1H), 4.26 (dd, J = 4.1, 2.1 Hz, 2H), 3.70 (t, J = 6.9 
Hz, 2H), 2.73 (t, J = 6.9 Hz, 2H). 13C NMR (75 MHz, CDCl3): δ 171.8 (C), 
147.1 (CH), 130.1 (CH), 128.3 (CH), 125.2 (CH), 122.5 (C), 120.6 (CH), 86.0 (C), 76.9 (C), 
69.5 (CH2), 69.3 (CH2), 20.9 (CH2). HRMS (APCI-FIA-TOF): m/z calculated for C12H13O3S 
([M+H]+) 237.0577, found 237.0580.
(E)-4-((4-(Thiophen-2-yl)but-3-yn-1-yl)oxy)but-2-enoic acid (1n)
This compound was prepared according to the previously described general 
procedure B, using 2-bromothiophene instead of iodobenzene. Amorphous 
yellow solid.1H NMR (300 MHz, CDCl3): δ 11.64 (brs, 1H), 7.22 – 7.12 (m, 
2H), 7.07 (dt, J = 15.7, 4.1 Hz, 1H), 6.93 (dd, J = 5.2, 3.6 Hz, 1H), 6.14 (dd, 
J = 15.7, 2.2 Hz, 1H), 4.23 (dd, J = 4.2, 2.1 Hz, 2H), 3.68 (t, J = 6.9 Hz, 2H), 
2.74 (t, J = 6.9 Hz, 2H).13C NMR (75 MHz, CDCl3): δ 171.8 (C), 147.0 (CH), 
131.6 (CH), 126.9 (CH), 126.4 (CH), 123.6 (C), 120.6 (CH), 90.5 (C), 75.0 (C), 69.5 (CH2), 
69.1 (CH2), 21.1 (CH2). HRMS (APCI-FIA-TOF): m/z calculated for C12H13O3S ([M+H]+) 
237.0577, found 237.0580.
S12
General procedure (C) for preparation of acid precursors 1p, 1q, 1r, 1s, 1t and 1u 
(exemplified for the synthesis of 4-Methyl-1-(6-phenylhex-5-yn-1-yl)-1H-pyrrole-3-carboxylic 
acid, 1r). 
5-Hexyn-1-ol (4.0 g, 40.8 mmol) was added to a solution of Et3N (11.3 mL, 81.5 mmol), Tosyl 
chloride (8.2 g, 42.8 mmol) and 4-Dimethylaminopyridine (747 mg, 6.1 mmol) in CH2Cl2 (60.8 
mL) at 0°C. The mixture was warmed to rt and stirred for 3 h. NH4Cl (sat) (80 mL) was then 
added, the organic phase separated, and the aqueous phase extracted twice with CH2Cl2 (30 
mL). The organic phases were dried and concentrated under vacuum. Purification of the crude 
residue by flash chromatography on silica gel (1:20 to 1:3 EtOAc: Hexanes) afforded hex-5-
yn-1-yl 4-methylbenzenesulfonate (S4) as colorless oil (10.1 g, 98 % yield). 1H NMR (300 MHz, 
CDCl3): δ 7.74 (d, J = 8.4 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 4.01 (t, J = 6.3 Hz, 2H), 2.41 (s, 
3H), 2.12 (td, J = 6.9, 2.7 Hz, 2H), 1.90 (t, J = 2.7 Hz, 1H), 1.80 – 1.67 (m, 2H), 1.51 (p, J = 
6.9 Hz, 2H). 13C NMR (75 MHz, CDCl3): δ 144.8 (C), 133.0 (C), 129.9 (CH), 127.8 (CH), 83.4 
(C), 70.0 (CH2), 69.0 (CH), 27.7 (CH2), 24.2 (CH2), 21.6 (CH3), 17.7 (CH2). HRMS (ESI-TOF): 
m/z calculated for C13H17O3S ([M+H]+) 253.0893, found 253.0893.
A Schlenk tube under argon equipped with a Teflon septum and magnetic stir bar was charged 
with CuI (22.6 mg, 0.12 mmol) and Pd(PPh3)4 (68.7 mg, 0.06 mmol). Et3N (7.9 mL), 
iodobenzene (0.53 mL, 4.7 mmol) and hex-5-yn-1-yl 4-methylbenzenesulfonate (S4, 600 mg, 
2.38 mmol) were sequentially added. The reaction mixture was stirred at rt. After 20 h, the 
reaction mixture was concentrated in vacuo. Purification of the crude product by flash 
chromatography on silica gel (1:20 to 1:4 EtOAc: Hexane) afforded 6-phenylhex-5-yn-1-yl-4-
methylbenzenesulfonate (S5) as a colorless oil (723 mg, 93% yield). 1H NMR (300 MHz, 
CDCl3): δ 7.79 – 7.74 (m, 2H), 7.37 – 7.33 (m, 2H), 7.30 – 7.28 (m, 1H), 7.28 – 7.22 (m, 4H), 
4.06 (t, J = 6.3 Hz, 2H), 2.38 – 2.30 (m, 5H), 1.85 – 1.73 (m, 2H), 1.65 – 1.53 (m, 2H). 13C 
NMR (75 MHz, CDCl3): δ 144.7 (C), 132.9 (C), 131.3 (CH), 129.8 (CH), 128.1 (CH), 127.6 
(CH), 127.5 (CH), 123.6 (C), 89.0 (C), 81.2 (C), 70.0 (CH2), 27.8 (CH2), 24.4 (CH2), 21.4 (CH3), 
Scheme S3. General procedure C for preparation of acid precursors
S13
18.6 (CH2). HRMS (ESI-TOF): m/z calculated for C19H21O3S ([M+H]+) 329.1208, found 
329.1206.
Following a modified procedure described by Schreiber and co-workers2, to a solution of ethyl 
4-methyl-1H-pyrrole-3-carboxylate (250 mg, 1.63 mmol) in anhydrous DMF (4 mL) at 0 ºC was 
added sodium hydride (60 % mineral oil) (97.9 mg, 2.45 mmol). After 20 minutes, 6-phenylhex-
5-yn-1-yl-4-methylbenzenesulfonate (540 mg, 1.64 mmol) was added. The reaction mixture 
was stirred at 85 °C for 16 hours. The reaction mixture was allowed to cool to room 
temperature, water (30 mL) and Et2O (10 mL) were successively added, and the layers were 
separated. The aqueous phase was extracted with Et2O (4 x 10 mL) and the combined organic 
phases were dried and concentrated. Purification of the crude residue by flash chromatography 
on silica gel (1:10 to 1:2 EtOAc: Hexanes) afforded ethyl 4-methyl-1-(6-phenylhex-5-yn-1-yl)-
1H-pyrrole-3-carboxylate (S6) as yellow pale oil (396 mg, 78 % yield). 1H NMR (300 MHz, 
CDCl3): δ 7.45 – 7.39 (m, 2H), 7.33 – 7.25 (m, 4H), 6.42 – 6.38 (m, 1H), 4.28 (q, J = 7.1 Hz, 
2H), 3.82 (t, J = 7.0 Hz, 2H), 2.43 (t, J = 6.9 Hz, 2H), 2.31 (s, 3H), 1.97 – 1.84 (m, 2H), 1.63 – 
1.50 (m, 2H), 1.35 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 165.3 (C), 131.4 (CH), 
128.2 (CH), 127.6 (CH), 126.4 (CH), 123.7 (C), 121.4 (C), 120.2 (C), 120.1 (CH), 114.0 (C), 
89.2 (C), 81.2 (C), 59.1 (CH2), 49.3 (CH2), 30.2 (CH2), 25.5 (CH2), 18.9 (CH2), 14.5 (CH3), 11.7 
(CH3). HRMS (APCI-FIA-TOF): m/z calculated for C20H24NO2 ([M+H] +) 310.1798, found 
310.1802.
Following a modified procedure described by Sieber and co-workers3, to a solution of ethyl 4-
methyl-1-(6-phenylhex-5-yn-1-yl)-1H-pyrrole-3-carboxylate (S6, 390 mg, 1.26 mmol) in EtOH 
(6.3 mL) was added an aqueous solution of KOH (0.5 mL, 10 M) and the reaction mixture was 
stirred for 24 h at room temperature. The solution was acidified by adding aqueous 1 M HCl, 
the reaction mixture extracted with EtOAc (4 x 10 mL), and the combined organic extracts were 
washed with brine (40 mL), dried and concentrated under reduced. Purification of the crude 
residue by flash chromatography on silica gel (1:5 to 2:1 EtOAc: Hexanes) afforded 4-methyl-
1-(6-phenylhex-5-yn-1-yl)-1H-pyrrole-3-carboxylic acid (1r) as a light-yellow solid, m.p. 77 -88 
ºC, (323 mg, 91 % yield). 1H NMR (300 MHz, CDCl3): δ 7.45 – 7.40 (m, 2H), 7.38 – 7.35 (m, 
1H), 7.35 – 7.27 (m, 3H), 6.46 – 6.42 (m, 1H), 3.89 (t, J = 6.9 Hz, 2H), 2.47 (t, J = 6.9 Hz, 2H), 
2.31 (s, 3H), 1.97 (p, J = 7.1 Hz, 2H), 1.61 (p, J = 7.1 Hz, 2H). 13C NMR (75 MHz, CDCl3): δ 
171.2 (C), 131.7 (CH), 128.4 (CH), 128.0 (CH), 127.8 (CH), 123.8 (C), 122.4 (C), 120.6 (CH), 
113.4 (C), 89.2 (C), 81.5 (C), 49.6 (CH2), 30.3 (CH2), 25.7 (CH2), 19.1 (CH2), 11.8 (CH3). HRMS 
(APCI-FIA-TOF): m/z calculated for C18H20NO2 ([M+H]+) 282.1491, found 282.1489.
S14
3-(Pent-3-yn-1-yloxy)benzoic acid (1p)
This compound was prepared according to the previously described 
general procedure C, using pent-3-yn-1-ol and methyl 3-hydroxybenzoate 
instead of 5-Hexyn-1-ol and ethyl 4-methyl-1H-pyrrole-3-carboxylate. 
White solid, m.p. 146 -147 ºC. 1H NMR (300 MHz, CDCl3): δ 10.37 (brs, 
1H), 7.73 (d, J = 7.7 Hz, 1H), 7.64 (s, 1H), 7.38 (t, J = 8.0 Hz, 1H), 7.17 
(dd, J = 8.3, 2.7 Hz, 1H), 4.11 (t, J = 7.1 Hz, 2H), 2.72 – 2.60 (m, 2H), 1.81 (t, J = 2.5 Hz, 3H). 
13C NMR (75 MHz, CDCl3): δ 172.2 (C), 158.8 (C), 130.7 (C), 129.7 (CH), 123.1 (CH), 121.2 
(CH), 115.4 (CH), 77.7 (C), 75.0 (C), 67.0 (CH2), 19.9 (CH2), 3.7 (CH3). HRMS (APCI-FIA-
TOF): m/z calculated for C12H12O3 ([M+H]+) 205.0859, found 205.0859. 
3-((5-Phenylpent-4-yn-1-yl)oxy)benzoic acid (1q)
This compound was prepared according to the previously described 
general procedure C, using pent-4-yn-1-ol and methyl 3-hydroxybenzoate 
instead of 5-Hexyn-1-ol and ethyl 4-methyl-1H-pyrrole-3-carboxylate. 
White solid, m.p. 116 -117 ºC. 1H NMR (300 MHz, CDCl3): δ 11.44 (brs, 
1H), 7.75 (d, J = 7.7 Hz, 1H), 7.68 (s, 1H), 7.47 – 7.38 (m, 3H), 7.33 – 7.26 (m, 3H), 7.20 (dd, 
J = 8.3, 2.6 Hz, 1H), 4.20 (t, J = 6.1 Hz, 2H), 2.67 (t, J = 6.9 Hz, 2H), 2.13 (p, J = 6.5 Hz, 2H). 
13C NMR (75 MHz, CDCl3): δ 172.4 (C), 159.1 (C), 131.7 (CH), 130.7 (C), 129.7 (CH), 128.3 
(CH), 127.8 (CH), 123.8 (C), 122.8 (CH), 121.1 (CH), 115.3 (CH), 89.0 (C), 81.4 (C), 66.8 
(CH2), 28.5 (CH2), 16.3 (CH2). HRMS (APCI-FIA-TOF): m/z calculated for C18H17O3 ([M+H]+) 
281.1171, found 281.1172. 
4-Methyl-1-(7-phenylhept-6-yn-1-yl)-1H-pyrrole-3-carboxylic acid (1s)
This compound was prepared according to the previously described 
general procedure C, using hept-6-yn-1-ol instead of 5-Hexyn-1-ol. 
Viscous orange oil. 1H NMR (300 MHz, CDCl3): δ 12.00 (brs, 1H), 7.45 
– 7.39 (m, 2H), 7.38 – 7.34 (m, 1H), 7.34 – 7.27 (m, 3H), 6.43 (s, 1H), 
3.84 (t, J = 6.9 Hz, 2H), 2.44 (t, J = 6.9 Hz, 2H), 2.31 (s, 3H), 1.83 (p, J = 7.1 Hz, 2H), 1.65 (p, 
J = 7.0 Hz, 2H), 1.55 – 1.43 (m, 2H). 13C NMR (75 MHz, CDCl3): δ 171.3 (C), 131.6 (CH), 128.3 
(CH), 128.0 (CH), 127.7 (CH), 123.9 (C), 122.3 (C), 120.6 (CH), 113.3 (C), 89.7 (C), 81.1 (C), 
49.9 (CH2), 30.7 (CH2), 28.2 (CH2), 25.9 (CH2), 19.3 (CH2), 11.8 (CH3). HRMS (APCI-FIA-
TOF): m/z calculated for C19H22NO2 F3 ([M+H]+) 296.1650, found 296.1645.
S15
3-((4-(Trimethylsilyl)but-3-yn-1-yl)oxy)benzoic acid (1t)
This compound was prepared according to the previously described 
general procedure C, using but-3-yn-1-ol and methyl 3-
hydroxybenzoate instead of 5-Hexyn-1-ol and ethyl 4-methyl-1H-
pyrrole-3-carboxylate4. White solid (5:1, SiMe3 : H). 1H NMR (300 MHz, 
CDCl3): δ 7.74 (dt, J = 7.7, 1.3 Hz, 1H), 7.64 (dd, J = 2.7, 1.5 Hz, 1H), 
7.39 (t, J = 7.9 Hz, 1H), 7.22 – 7.12 (m, 1H), 4.14 (t, J = 7.2 Hz, 2H), 2.75 (t, J = 7.3 Hz, 2H), 
0.17 (s, 9H). 13C NMR (75 MHz, CDCl3): δ 172.3 (C), 151.8 (C), 130.7 (C), 129.7 (CH), 123.1 
(CH), 121.2 (CH), 115.3 (CH), 102.4 (C), 86.8 (C), 66.5 (CH2), 21.0 (CH2), 0.2 (CH3). HRMS 
(APCI-FIA-TOF): m/z calculated for C14H19O3Si ([M+H]+) 263.1097, found 263.1098.
3-(Penta-2,3-dien-1-yloxy)benzoic acid (1u)
This compound was prepared according to the previously described general 
procedure C, using penta-2,3-dien-1-ol and methyl 3-hydroxybenzoate 
instead of 5-Hexyn-1-ol and ethyl 4-methyl-1H-pyrrole-3-carboxylate. White 
solid. 1H NMR (300 MHz, CDCl3): δ 9.20 (s, 1H), 7.71 (dt, J = 7.7, 1.3 Hz, 
1H), 7.65 (dd, J = 2.7, 1.4 Hz, 1H), 7.36 (t, J = 7.9 Hz, 1H), 7.16 (ddd, J = 
8.3, 2.6, 1.0 Hz, 1H), 5.37 – 5.20 (m, 2H), 4.60 (dd, J = 6.4, 2.6 Hz, 2H), 1.68 (dd, J = 6.8, 3.4 
Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 206.3 (C), 172.2 (C), 158.5 (C), 130.9 (C), 129.6 (CH), 
122.9 (CH), 121.40 (CH), 115.7 (CH), 87.9 (CH), 86.8 (CH), 66.7 (CH2), 14.0 (CH3). HRMS 
(APCI-FIA-TOF): m/z calculated for C12H13O3 ([M+H]+) 205.0858, found 205.0859.
Procedure for preparation of (E)-4-(Benzyl(3-phenylprop-2-yn-1-yl)amino)but-2-enoic 
acid 1o.
Following a modified procedure described by ourselves5, N-Benzyl-3-phenylprop-2-yn-1-
amine (2.5 g, 11.3 mmol) was added to a suspension of K2CO3 (2.6 g, 19.2 mmol) in THF (39 
mL) at -10 ºC. After stirring for 15 min, ethyl (E)-4-bromobut-2-enoate (2.7 mL, 14.7 mmol) was 




Scheme S4. Synthesis of (E)-4-(Benzyl(3-phenylprop-2-yn-1-yl)amino)but-2-enoic acid 
1o.
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water and extracted with Et2O (3x40 mL). The organic phases were dried, filtered and 
concentrated. Purification of the crude residue by flash chromatography on silica gel gave 
(1:20 to 1:1 EtOAc: Hexanes) ethyl (E)-4-(benzyl(3-phenylprop-2-yn-1-yl)amino)but-2-enoate 
(S7) as a light-yellow oil, (3.1 g, 84 % yield). 1H NMR (300 MHz, CDCl3): δ 7.54 – 7.48 (m, 2H), 
7.46 – 7.39 (m, 2H), 7.39 – 7.30 (m, 6H), 7.05 (dtd, J = 15.7, 6.0, 1.1 Hz, 1H), 6.15 (dt, J = 
15.7, 1.3 Hz, 1H), 4.24 (q, J = 7.2 Hz, 2H), 3.78 (s, 2H), 3.58 (s, 2H), 3.43 (dd, J = 6.0, 1.7 Hz, 
2H), 1.33 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 166.4 (C), 145.8 (CH), 138.4 (C), 
131.9 (CH), 129.1 (CH), 128.5 (CH), 128.4 (CH), 128.3 (CH), 127.4 (CH), 123.4 (CH), 123.2 
(C), 86.1 (C), 84.0 (C), 60.5 (CH2), 58.0 (CH2), 54.4 (CH2), 42.8 (CH2), 14.4 (CH3). HRMS 
(APCI-FIA-TOF): m/z calculated for C22H23NO2 ([M+H]+) 333.1729, found 333.1727.
A NaOH aqueous solution (3 mL, 1M) was added to a solution that contains ethyl (E)-4-
(benzyl(3-phenylprop-2-yn-1-yl)amino)but-2-enoate (1.0 g, 3.0  mmol) in MeOH (4.5 mL). The 
reaction mixture was stirred at rt. After 8 h, a solution of HCl (5 %) was added to adjust the pH 
to 2. The mixture was extracted with EtOAc (3 x 20 mL). The combined organic layers were 
dried and the solvent removed in vacuo. Purification of the crude product by flash 
chromatography on silica gel (1:5 to 2:1 EtOAc: Hexane) afforded (E)-4-(benzyl(3-phenylprop-
2-yn-1-yl)amino)but-2-enoic acid (1o) as a colorless oil, (450 mg, 49 % yield). 1H NMR (300 
MHz, CDCl3): δ 11.05 (s, 1H), 7.51 – 7.46 (m, 1H), 7.40 (ddd, J = 8.3, 6.8, 1.7 Hz, 2H), 7.36 – 
7.27 (m, 4H), 7.14 (dt, J = 15.7, 6.0 Hz, 1H), 6.14 (dd, J = 15.7, 1.6 Hz, 1H), 3.78 (s, 2H), 3.58 
(s, 2H), 3.46 (dd, J = 6.1, 1.7 Hz, 2H). 13C NMR (75 MHz, CDCl3): δ 171.4 (C), 148.0 (CH), 
137.9 (C), 131.9 (CH), 129.3 (CH), 128.6 (CH), 128.47 (CH), 128.46 (C), 128.4 (CH), 127.6 
(CH), 123.1 (CH), 86.4 (C), 83.6 (C), 58.0 (CH2), 54.4 (CH2), 42.7 (CH2). HRMS (APCI-FIA-
TOF): m/z calculated for C20H20NO2 ([M+H]+) 306.1489, found 306.1489.
Further insights into the cascade DA transformation
Preliminary tests on the amount of dienophile used were performed with 2a, as in this way we would 
also confirm the viability of the tandem process on other substrates than 2d. Heating 2a in presence 
of 1 equiv of the maleimide led exclusively to the cascade DA adduct 5 (47 %), and recovery of the 
remaining starting material 2a (52 %). This result suggests that the intermediate resulting from the 
initial cycloadditions reacts faster than the initial pyrone. 
 
An oven dried sealed tube equipped with a magnetic stir bar was charged with N-phenylmaleimide 
(28.3 mg, 0.16 mmol), 4-phenyl-3H-furo[3,4-c]pyran-6(1H)-one (2a) (35 mg, 0.16 mmol) and dioxane 
(1.3 mL). The reaction mixture was then stirred at 150 °C. After 72 h, the reaction mixture was 
concentrated in vacuo. Purification of the crude product by flash chromatography on silica gel (1:10 
to 2:1 EtOH: Hexane) afforded the cascade product 5 as a white solid (39.6 mg, 47 % yield). Light 
yellow solid. 1H NMR (300 MHz, CDCl3): δ 7.49 – 7.31 (m, 10H), 7.11 – 7.04 (m, 5H), 5.08 (t, J = 5.2 
Hz, 2H), 4.72 (t, J = 5.2 Hz, 2H), 4.18 (t, J = 3.0 Hz, 1H), 3.62 (d, J = 8.0 Hz, 2H), 3.34 (dd, J = 8.0, 
3.0 Hz, 2H). 13C NMR (75 MHz, CDCl3): δ 175.0 (C), 173.5 (C), 138.9 (C), 137.5 (C), 137.1 (C), 131.3 
(C), 129.5 (CH), 129.2 (CH), 128.0 (CH), 126.5 (CH), 76.4 (CH2), 75.2 (CH2), 51.2 (C), 49.8 (CH), 



















Scheme S5. Cascade Diels-Alder reaction
S18
X-Ray Crystallographic Details
CCDC 1885153 (2c) and CCDC 1885154 (4) contain the supplementary crystallographic data for this 
paper. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre 
via www.ccdc.cam.ac.uk/data_request/cif.
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Figure S1. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 8-phenyloct-7-yn-1-ol (S1)
S20
 Figure S2. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of ethyl (E)-10-phenyldec-2-en-9-ynoate (S2)
S21
 Figure S3. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of ethyl (E)-4-((5-Phenylpent-4-yn-1-yl)oxy)but-2-enoate (S3)
S22
 
Figure S4. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of hex-5-yn-1-yl 4-methylbenzenesulfonate (S4)
S23
 
Figure S5. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 6-phenylhex-5-yn-1-yl-4-methylbenzenesulfonate (S5)
S24
 Figure S6. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of ethyl 4-methyl-1-(6-phenylhex-5-yn-1-yl)-1H-pyrrole-3-carboxylate (S6)
S25
 Figure S7. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of ethyl (E)-4-(benzyl(3-phenylprop-2-yn-1-yl)amino)but-2-enoate (S7)
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Figure S8. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of (E)-4-((3-Phenylprop-2-yn-1-yl)oxy)but-2-enoic acid (1a)
S27
 
Figure S9. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of (E)-4-((4-Phenylbut-3-yn-1-yl)oxy)but-2-enoic acid (1b) 
S28
 Figure S10. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of (E)-9-Phenylnon-2-en-8-ynoic acid (1c)
S29
 Figure S11. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of (E)-4-((5-Phenylpent-4-yn-1-yl)oxy)but-2-enoic acid (1d)
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Figure S12. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of (E)-10-Phenyldec-2-en-9-ynoic acid (1e)
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 Figure S13. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of (E)-4-((6-Phenylhex-5-yn-1-yl)oxy)but-2-enoic acid (1f)
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Figure S14. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of (E)-4-(Hept-2-yn-1-yloxy)but-2-enoic acid (1g)
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 Figure S15. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of (E)-2-Methyl-8-phenyloct-2-en-7-ynoic acid (1h)
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Figure S16. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of (E)-2-Methyl-9-phenylnon-2-en-8-ynoic acid (1i)
S35
 
Figure S17. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of (E)-9-(3,5-Dimethylphenyl)-2-methylnon-2-en-8-ynoic acid (1j)
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 Figure S18. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 
75 MHz) of (E)-2-Methyl-9-(naphthalen-1-yl)non-2-en-8-ynoic acid (1k)
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Figure S19. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 
75 MHz) of (E)-2-Methyl-9-(4-(trifluoromethyl)phenyl)non-2-en-8-ynoic acid (1l)
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 Figure S20. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of (E)-4-((4-(Thiophen-3-yl)but-3-yn-1-yl)oxy)but-2-enoic acid (1m)
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Figure S21. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of (E)-4-((4-(Thiophen-2-yl)but-3-yn-1-yl)oxy)but-2-enoic acid (1n)
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Figure S22. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of (E)-4-(Benzyl(3-phenylprop-2-yn-1-yl)amino)but-2-enoic acid (1o)
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Figure S23. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 3-(Pent-3-yn-1-yloxy)benzoic acid (1p)
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Figure S24. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 3-((5-Phenylpent-4-yn-1-yl)oxy)benzoic acid (1q)
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 Figure S25. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 4-Methyl-1-(6-phenylhex-5-yn-1-yl)-1H-pyrrole-3-carboxylic acid (1r)
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 Figure S26. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 4-Methyl-1-(7-phenylhept-6-yn-1-yl)-1H-pyrrole-3-carboxylic acid (1s)
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 Figure S27. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 3-((4-(Trimethylsilyl)but-3-yn-1-yl)oxy)benzoic acid (1t)
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 Figure S28. 1H NMR (CDCl3, 300 MHz) ,DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 3-(Penta-2,3-dien-1-yloxy)benzoic acid (1u)
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Figure S29. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 4-Phenyl-3H-furo[3,4-c]pyran-6(1H)-one (2a)
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 Figure S30. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 1-Phenyl-7,8-dihydropyrano[4,3-c]pyran-3(5H)-one (2b)
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Figure S31. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 1-Phenyl-5,6,7,8-tetrahydro-3H-isochromen-3-one (2c)
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Figure S32. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 1-Phenyl-8,9-dihydro-7H-pyrano[4,3-c]oxepin-3(5H)-one (2d)
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Figure S33. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 1-Phenyl-6,7,8,9-tetrahydrocyclohepta[c]pyran-3(5H)-one (2e)
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Figure S34. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 1-Phenyl-7,8,9,10-tetrahydropyrano[4,3-c]oxocin-3(5H)-one (2f)
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Figure S35. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 4-Butyl-3H-furo[3,4-c]pyran-6(1H)-one (2g)
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Figure S36. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 4-Methyl-1-phenyl-6,7-dihydrocyclopenta [c]pyran-3(5H)-one (2h)
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Figure S37. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 4-Methyl-1-phenyl-5,6,7,8-tetrahydro-3H-isochromen-3-one (2i)
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Figure S38. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 
75 MHz) of 1-(3,5-Dimethylphenyl)-4-methyl-5,6,7,8-tetrahydro-3H-isochromen-3-one (2j)
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Figure S39. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 
75 MHz) of 4-Methyl-1-(naphthalen-1-yl)-5,6,7,8-tetrahydro-3H-isochromen-3-one (2k)
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Figure S40. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 4-Methyl-1-(4-(trifluoromethyl)phenyl)-5,6,7,8-tetrahydro-3H-isochromen-3-one (2l)
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Figure S41. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 1-(Thiophen-3-yl)-7,8-dihydropyrano[4,3-c]pyran-3(5H)-one (2m)
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Figure S42. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 
75 MHz) of 1-(Thiophen-2-yl)-7,8-dihydropyrano[4,3-c]pyran-3(5H)-one (2n)
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Figure S43. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 2-Benzyl-4-phenyl-2,3-dihydropyrano[3,4-c]pyrrol-6(1H)-one (2o) 
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Figure S44. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 4-Methyl-2,3-dihydro-6H-pyrano[3,4,5-de]chromen-6-one (2p)
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Figure S45. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 5-Phenyl-3,4-dihydro-2H,7H-oxepino[4,3,2-de]isochromen-7-one (2q)
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Figure S46. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of 2-Methyl-5-phenyl-6,7,8,9-tetrahydro-3H-4-oxa-9a-azabenzo[cd] azulen-3-one (2r)
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 Figure S47. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 







Figure S48. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 












Figure S49. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 












Figure S50. 1H NMR (CDCl3, 300 MHz), DEPT 13C NMR (CDCl3, 75 MHz) and 13C NMR Spectra (CDCl3, 75 
MHz) of compound 5
